Andrew P Riley

Title: Innovations of Andrew P. Riley

Introduction

Andrew P. Riley is an accomplished inventor based in Lawrence, Kansas. He is known for his significant contributions to the field of pharmacology, particularly in the development of non-morphinan-like mu opioid receptor agonists. His work aims to provide alternatives to traditional opioid medications, which often come with severe side effects.

Latest Patents

Andrew P. Riley holds a patent for "Agonists of the mu opioid receptor." This technology is directed to compounds, compositions, and methods related to mu opioid receptor agonists that are not derived from morphinan. The compounds demonstrate remarkable potency and selectivity for the mu opioid receptor over the kappa opioid receptor. Additionally, they exhibit a significant reduction or essentially an absence of the negative side effects commonly associated with morphine-derived compounds. He has 1 patent to his name.

Career Highlights

Andrew is affiliated with the University of Kansas, where he conducts research and develops innovative solutions in the field of opioid receptor pharmacology. His work is crucial in addressing the ongoing opioid crisis by exploring safer alternatives for pain management.

Collaborations

Andrew has collaborated with notable colleagues such as Thomas Edward Prisinzano and Chad E. Groer. Their combined expertise enhances the research and development of new therapeutic options.

Conclusion

Andrew P. Riley's innovative work in developing mu opioid receptor agonists represents a significant advancement in pharmacology. His contributions aim to improve pain management while minimizing the risks associated with traditional opioid medications.